Clinical Trial Update: Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ABI-007 (nab-paclitaxel) in previously treated patients with metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Abraxane (nab-paclitaxel) (nab-paclitaxel)

Snippet

Sponsor: Celgene | Conditions: Melanoma, Metastases | Phase 2 | Status: COMPLETED